Orexo: U.S. FDA Approves ZUBSOLV® for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence
FDA accepts a Supplemental New Drug Application for review of Brintellix (vortioxetine) clinical trial data that assessed cognitive function in patients with major depressive disorder
Cipla announces a new respiratory inhaler: Synchrobreathe (SB), a state-of-the-art breath-actuated inhaler which will bring relief to millions of patients with Obstructive Airway Disease
CVS Health Research Institute Encourages Reconsideration of Current Cholesterol Management Guidelines as New Class of High-cost Drugs Hit the Market
Novo Nordisk increased operating profit in Danish kroner by 57% in the first six months of 2015 to DKK 26.3 billion
Endo Divests Non-Core Business Lines from Litha Healthcare Group International Business, Enhancing Focus on Specialty Pharmaceuticals
Two Altasciences Executives Named PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry
LAVAL, Quebec--Altasciences, a provider of top tier customer-tailored early phase clinical trial services, is pleased to announce that Chris Perkin, CEO at Altasciences, and his colleague, Dr. Brad...